Cogent Share Price

Cogent Share Price

NASDAQ: COGT | Mid Cap | Healthcare
$28.05
+$0.30 (1.08%) Last updated on 19 Nov, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cogent Stock Performance

Open
$28.15
Prev. Close
$27.75
Circuit Range
N/A
Day Range
$27.91 - $28.75
Year Range
$26.39 - $43.55
Volume
1,07,833
Average Traded
$28.14

Cogent Share Price Today

As of 19 November 2026, Cogent Biosciences, Inc.'s share price is $28.05. The stock opened at $28.15, compared to its previous close of $27.75. During today's trading session, Cogent Biosciences, Inc.'s share price traded between $27.91 and $28.75, with an average price of $28.33. Over the past 52 weeks, the stock has recorded a high of $43.55 and a low of $26.39. In terms of performance, Cogent Biosciences, Inc.'s share price has declined by 19.79% over the last six months and is down 30.28% on a year-on-year basis.

Cogent Share Price Chart

Line chart of the Cogent price trend over the selected period. The price rose overall, ranging from 27.74 to 28.77, ending at 28.05.
$27.91$28.75
L
Show Current Price
H

Cogent Stock Fundamentals & Key Indicators

Market Cap
$3.62B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.11
Revenue (TTM)
$0.00
Return On Equity (TTM)
-70.94%
Profit Margin
N/A
Debt to Equity
0.43
Quarterly Earnings Growth YoY
-16.37%

Cogent Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$88.42-$86.02-$88.93-$102.89
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.71%-3.38%-15.70%

Cogent Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$101.46-$154.93-$201.42-$277.89
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-52.70%-30.01%-37.97%

Cogent Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets27.2531.4342.6735.84
Current Assets910.36296.47270.77264.97
Total Assets937.61327.9313.44300.81
Non Current Liabilities237.2815.917.4718.23
Current Liabilities63.9555.7138.1726.85
Total Liabilities301.2471.6155.6445.08
Shareholders' Equity636.37256.29257.8255.74

Cogent Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-264.44-207.79-153.62-118.64
Investing-399.5338.28-97.82-124.72
Financing878.23214.45163.54163.56

Corporate Actions

Split
Ex-date: 09 Nov 2020

About Cogent

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Cogent Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$31.37
$28.05
-9.61%
Oct 2026
$32.01
$31.02
-3.27%
Sep 2026
$34.90
$32.08
-13.50%
Aug 2026
$38.40
$37.08
-4.70%
Jul 2026
$38.71
$38.91
+0.52%
Jun 2026
$34.90
$38.71
+10.68%
May 2026
$36.06
$34.98
-2.28%
Apr 2026
$37.66
$35.79
-7.04%
Mar 2026
$38.09
$38.50
-0.99%
Feb 2026
$36.41
$38.88
+8.22%
Jan 2026
$35.73
$35.93
+1.15%
Dec 2025
$39.43
$35.52
-11.73%

Cogent Share Price FAQs